AstraZeneca’s Imfinzi breaks decade Long Drought in Cholangiocarcinoma By Steve|2024-10-11T16:07:34+10:00December 5th, 2023|Categories: All, Immunotherapy, Z-Legacy|Tags: AstraZeneca, Imfinzi, immunotherapy| Read More 0
Transforming Cancer Perceptions: The Power of Objectivity By Steve|2024-10-11T16:07:37+10:00December 4th, 2023|Categories: All, Z-Legacy|Tags: Objectivity, Perception, Will| Read More 0
Exploring HIPEC Surgery: A Potential Ally in Abdominal Cancer Battles By Steve|2024-10-11T16:07:40+10:00November 24th, 2023|Categories: All, Education, Z-Legacy|Tags: HiPEC, Surgery| Read More 0
Clarifying: What is the Checkpoint Pathway? By Steve|2024-10-11T16:07:43+10:00November 20th, 2023|Categories: All, Education, Z-Legacy|Tags: Checkpoint Pathway| Read More 0
Two brothers Same Diagnosis – 6 Months to Live. By Steve|2024-10-11T16:07:47+10:00November 20th, 2023|Categories: Patient Story, Z-Legacy|Tags: Graeme Holmes, Steve Holmes| Read More 0
The Basics difference between Gem/Cis with Durvalumab vs. Keytruda By Steve|2024-10-11T16:07:49+10:00November 18th, 2023|Categories: All, Updates, Z-Legacy|Tags: immunotherapy| Read More 2
Merck’s Keytruda: A New Hope in Biliary Tract Cancer By Steve|2024-10-11T16:07:51+10:00November 5th, 2023|Categories: All, Z-Legacy|Tags: durvalumab, Infinzi, Keytruda| Read More 0
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2024-10-11T16:07:53+10:00August 29th, 2023|Categories: All, Media, Updates, Z-Legacy|Tags: durvalumab| Read More 0
Testimonials By Steve|2024-10-11T16:07:54+10:00August 4th, 2023|Categories: All, Z-Legacy| Read More 0
Steven West: Cholangio Survivor By Steve|2024-10-11T16:07:55+10:00August 2nd, 2023|Categories: All, Testimonials, Z-Legacy|Tags: Testimonials| Read More 0